The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Long-Term Treatment with Omeprazole for Refractory Reflux Esophagitis: Efficacy and Safety
Abstract
OBJECTIVE: To evaluate the long-term efficacy and safety of omeprazole in patients with gastroesophageal reflux disease resistant to treatment with histamine-2 (H2)-receptor antagonists. DESIGN: Cohort analytic study with a mean follow-up of 48 months (range, 36 to 64 months). SETTING: Patients receiving ambulatory care from referral centers. PATIENTS: 91 patients with gastroesophageal reflux disease resistant to treatment with an H2-receptor antagonist but subsequently responsive to 40 mg of omeprazole daily. INTERVENTION: Open maintenance therapy consisting of 20 mg of omeprazole daily in 86 patients and 40 mg daily in 5 patients. OUTCOME MEASURES: Endoscopy to assess healing; side effects, laboratory values, fasting serum gastrin level, and gastric corpus biopsies to assess safety. RESULTS: Esophagitis recurred in 47% of the patients receiving 20 mg of omeprazole daily, but all rehealed after the dose was doubled. Seven of 40 patients (18%) had a second relapse after a mean follow-up time of 24 months (range, 9 to 36 months) that was successfully treated with a further 20-mg dose increment for a mean period of 36 months (range, 6 to 39 months). Median gastrin levels increased initially from 60 ng/L before study entry to 162 ng/L (P < 0.01) with treatment and reached a plateau during maintenance treatment. Very high gastrin levels (> 500 ng/L) were observed in a subgroup (11%) of patients. The incidence of micronodular hyperplasia increased from 2.5% of the patients at first biopsy to 20% at the last biopsy (P = 0.001), with a corresponding progression of gastritis to subatrophic or atrophic gastritis from less than 1% to 25% (P < 0.001), which was more pronounced in patients with very high serum gastrin levels. CONCLUSIONS: Maintenance therapy with omeprazole was effective for at least 5 years in patients with gastroesophageal reflux disease resistant to treatment with H2-receptor antagonists. Treatment was accompanied by a persistent increase in serum gastrin levels and an increase of micronodular argyrophil cell hyperplasia and subatrophic or atrophic gastritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of gastrointestinal mucosal growth
Johnson, L. R. (1988) · Physiological Reviews · doi:10.1152/physrev.1988.68.2.456 · Cited by 325
Long-term omeprazole therapy in peptic ulcer disease: Gastrin, endocrine cell growth, and gastritis
Lamberts, R., Creutzfeldt, W., Strüber, H. G., Brunner, G., & Solcia, E. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90344-c · Cited by 323
Klinkenberg-Knol, E. C., Festen, H. P. M., Jansen, J. M. B. J., Meuwissen, S. G. M., & Lamers, C. B. H. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91726-0 · Cited by 276
Self-citationSandmark, S., Carlsson, R., Fausa, O., & Lundell, L. (1988) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528809093923 · Cited by 268
Gastrin stimulates the self-replication rate of enterochromaffinlike cells in the rat stomach
Ryberg, B., Tielemans, Y., Axelson, J., Carlsson, E., Håkanson, R., Mattsson, H., Sundler, F., & Willems, G. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90610-d · Cited by 170
Jansen, J. B. �. �., Klinkenberg–Knol, E. C., Meuwissen, S. G. M., de Bruijne, J. W., Festen, H. P. M., Snel, P., Ae, L., Biemond, I., & Lamers, C. B. H. W. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90946-x · Cited by 120
Self-citationPentagastrin stimulates in vitro growth of normal and malignant human colon epithelial cells
Sirinek, K. R., Levine, B. A., & Moyer, M. P. (1985) · The American Journal of Surgery · doi:10.1016/s0002-9610(85)80006-4 · Cited by 120
Activation and Hyperplasia of Gastrin and Enterochromaffin-Like Cells in the Stomach
Håkanson, R., Böttcher, G., Sundler, F., & Vallgren, S. (2009) · Digestion · doi:10.1159/000199380 · Cited by 91
Qualitative Studies of Gastric Endocrine Cells in Patients Treated Long-term with Omeprazole
Solcia, E., Rindi, G., Havu, N., & Elm, G. (1989) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528909091260 · Cited by 79
Self-citationVillako, K., KEKKI, M., Maaroos, H.-I., Sipponen, P., Uibo, R., Tammur, R., & Tamm, A. O. (1991) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529109104000 · Cited by 75
Cited by
Updated Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease
DeVault, K. R., & Castell, D. O. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41217.x · Cited by 1,130
An evidence-based appraisal of reflux disease management — the Genval Workshop Report
Dent, J., Brun, J., Fendrick, A. M., Fennerty, M. B., Janssens, J., Kahrilas, P. J., Lauritsen, K., Reynolds, J. C., Shaw, M., & Talley, N. J. (1998) · Gut · doi:10.1136/gut.44.2008.s1 · Cited by 890
Kuipers, E. J., Lundell, L., Klinkenberg-Knol, E. C., Havu, N., Festen, H. P. M., Liedman, B., Lamers, C. B. H. W., Jansen, J. B. M. J., Dalenbäck, J., Snel, P., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604183341603 · Cited by 769
Self-citationKulke, M. H., & Mayer, R. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903183401107 · Cited by 741
Wang, T. C., Dangler, C. A., Chen, D., Goldenring, J. R., Koh, T., Raychowdhury, R., Coffey, R. J., Ito, S., Varro, A., Dockray, G. J., et al. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70412-4 · Cited by 583
Metadata
- Authors
- Klinkenberg-Knol, E. C., Festen, H. P. M., Jansen, J. B. M. J., Lamers, C. B. H. W., Nelis, F., Snel, P., Luckers, A., Dekkers, C. P. M., Havu, N., & Meuwissen, S. G. M.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1994-08-01
- Volume
- 121
- Issue
- 3
- Pages
- 161-167
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2005551571
- Cited by
- 422
- References
- 15
- FWCI
- 32.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-Term Treatment with Omeprazole for Refractory Reflux Esophagitis: Efficacy and Safety. https://app.cochat.ai/papers/10.7326/0003-4819-121-3-199408010-00001
- The paper
- Klinkenberg-Knol, E. C., Festen, H. P. M., Jansen, J. B. M. J., Lamers, C. B. H. W., Nelis, F., Snel, P., Luckers, A., Dekkers, C. P. M., Havu, N., & Meuwissen, S. G. M. (1994). Long-Term Treatment with Omeprazole for Refractory Reflux Esophagitis: Efficacy and Safety. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-121-3-199408010-00001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.